• slide1.jpg
  • slide2.jpg
  • slide3.jpg
  • slide4.jpg

Board of Directors

President: Judy Chernos, PhD, FCCMG

Judy Chernos is an Associate Professor in the Department of Medical Genetics, University of Calgary and is a senior Cytogeneticist at the Alberta Children’s Hospital.  She obtained her BSc in Zoology and Anthropology from the University of Toronto.  After moving west, she completed a PhD from the University of Calgary in Medical Genetics (1988) examining the effects of cryopreservation on chromosomal anomalies in gametes, followed by CCMG post-doctoral training in Cytogenetics.  She has been a Fellow of the CCMG since 1991.  Dr. Chernos is a keen educator at all levels.  Her longstanding scientific interest is in elucidating the nature of unique constitutional chromosome anomalies using traditional and genomic technologies and correlating with clinical phenotypes.


Secretary: Tanya Nelson, PhD, FCCMG

NelsonT photoDr. Tanya Nelson is a clinical Molecular Geneticist and Head of the Division Laboratory Genetics & Genomics at the BC Children’s and BC Women’s Hospitals, and a UBC Clinical Professor in the Department of Pathology & Laboratory Medicine. As a Chair or member of CCMG committees, Dr. Nelson has collaborated on numerous guideline and position statements, both in the prenatal and postnatal setting. She is also actively involved in CCMG training, and is the Director of the UBC CCMG Molecular Genetics post-graduate fellowship program.


 Treasurer:  Jean McGowan-Jordan, PhD, FCCMG

Jean McGowan-JordanJean McGowan-Jordan is the Head of the Regional Genetics Diagnostic Lab at CHEO and an Associate Professor in the Department of Pathology and Laboratory Medicine at the University of Ottawa. After completing fellowships in Molecular Genetics and Cytogenetics in Ottawa and Kingston, she was credentialed in both specialties through the CCMG in 2002.

Jean is Laboratory Director for the CHEO Genetics Labs, working in close collaboration with medical and operations leadership. She has served as Chair of the CHEO/University of Ottawa CCMG Fellowship Committee and the CCMG Cytogenetics Committee. Currently, Jean is Chair of the Standing Committee for the International System for Human Cytogenomic Nomenclature (ISCN) and was a co-editor of ISCN 2013 and ISCN 2016.
 


  Vice President: TBD


 Member:  Marjan Nezarati, MD, FRCPC, FCCMG


 Member: Murray Potter, MD, FRCPC, FCCMG

http://fhs.mcmaster.ca/pathology/images/potter-2012.jpgProfessor, Department of Pathology and Molecular Medicine, McMaster University

Dr. Potter spends most of his professional time in the area of biochemical genetics and newborn screening. Direct clinical duties include running Metabolic Genetic and Newborn Screening clinics at McMaster Children's Hospital and directing the Biochemical Genetics Laboratory at the Hamilton Regional Laboratory Medicine Program.

The major focus of Dr. Potter’s research is on inborn errors of metabolism. This encompasses clinical research in the diagnosis and management of these disorders and the development of new/improved mass-spectrometry diagnostic and monitoring tests. Dr. Potter’s educational contributions include undergraduate, medical student and post-graduate teaching at McMaster University. He is also involved in local education administration (Associate Chair Education, Department of Pathology and Molecular Medicine) and national assessment (Royal College of Physicians and Surgeons and Canadian College of Medical Geneticists examinations).


Member: Linlea Armstrong, BSc, MD, FRCPC, FCCMG

armstrong2Provincial Medical Genetics Programme, BC Women's Hospital
Linlea Armstrong is a Clinical Geneticist who cares for individuals and families with genetic and genomic concerns.  Passionate about working with learners and finding ways to optimize the training of future health care providers, she serve as Clinical Education Director within her department, which encompasses the responsibilities of Program Director for the Royal College residency program, Medical Director for the Masters of Genetic Counselling program, and Theme Lead for the Genetics and Genomics Theme in the MD Undergraduate Program.


Member: Leslie Turner, BSc, MD, FRCPC, FCCMG

Associate Professor, Discipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland

Dr. Turner is a clinical geneticist.  She is the Medical Director of the Newborn Screening Program.  Her research interests include newborn screening and consent.  She is also interested in Inherited Metabolic Diseases and is part of the Canadian Inherited Metabolic Disease Network.
 
Dr. Turner is the lead for the undergraduate Medical Genetics curriculum and chairs the Medical Genetics graduate course.


Member: Tracy Stockley, PhD, FCCMG

Research location: Toronto General Hospital/Research Institute (UHN)
Primary Research Area: Genetics, Genomics & Proteomics
Secondary Research Area: Cancer
Research Statement:

Dr. Stockley’s research interests include development of genomic tests for molecular diagnostics, application of new technologies such as Next-Generation Sequencing to clinical care for acquired and inherited disease, and quality management for high-complexity clinical laboratory testing.


Past-President: Gail Graham, MSc, MD, FRCPC, FCCMG

GailGraham 2Dr. Graham obtained her MSc in Human and Medical Genetics in 1988 and her MD in 1992, both at Queen’s University.  She completed her FRCPC in Medical Genetics at McGill University in 1997. She has 20 years’ experience as a clinical geneticist, having practiced in traditional hospital clinic settings, via Telehealth and in outreach settings in Alberta and Ontario. She served as the Sudbury Medical Advisor in the Northern Regional Genetics Program for 9 years while based in Ottawa. She became Chief of the Eastern Ontario Regional Genetics Program/CHEO Department of Genetics in 2011.